0000899243-20-004316.txt : 20200212
0000899243-20-004316.hdr.sgml : 20200212
20200212171505
ACCESSION NUMBER: 0000899243-20-004316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryan Jason
CENTRAL INDEX KEY: 0001585017
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 20605402
MAIL ADDRESS:
STREET 1: C/O FOUNDATION MEDICINE, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B3501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0001690585
Magenta Therapeutics, Inc.
MGTA
0001585017
Ryan Jason
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Stock Option (Right to Buy)
12.28
2020-02-10
4
A
0
75000
0.00
A
2030-02-09
Common Stock
75000
75000
D
This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.
Title: Chief Operating and Financial Officer
/s/ Zoran Zdraveski, Attorney-in-Fact for Jason Ryan
2020-02-12